Kijimea is a recognised medical device developed for the treatment of Irritable Bowel Syndrome with typical symptoms such as constipation, diarrhoea, abdominal pain, flatulence and bloating.
The active ingredient in these products is the unique bifidobacterium strain B. bifidum MIMBb75. This component attaches itself to the cells of the intestinal wall, reducing the chance that pathological bacteria can reach the intestinal wall. This way the intestinal wall is protected against further irritations.
The Kijimea products contain no preservatives, sweeteners, flavourings, lactose or gluten and are extremely suitable for patients with diabetes. In addition, the products do not contain gelatin.